Skip to main content

Table 1 Clinical summary, management, and outcome of all reported cases of isilated Nocardia scleritis

From: Nocardia scleritis—clinical presentation and management: a report of three cases and review of literature

Sl no.

Author

Eye

Age

Sex

Predisposing factor

Duration of symptoms

Presenting VA

Final VA

Treatment—medical

Treatment—surgical

Outcome

1

Kattan [3]

OD

63

F

Scleral buckle, cataract surgery

2 weeks

1/200

NA

Topical and TMP-SMX (iv)

Eviseration

Eviseration

2

King [5]

OD

77

M

Scleral buckle, cataract surgery

14 weeks

20/60

20/40

Topical 10% sulphacetamide, TMP-SMX (iv)

Buckle removal

Resolved

3

Brooks [4]

OS

90

F

Cataract surgery

5 weeks

20/80

NA

Topical amikacin, topical and oral TMP-SMX

Surgical debridement, scleral patch graft

Resolved

4

Basti [2]

OD

58

M

Injury with vegetable material, steroids

1 month

20/200

20/40

Cefazolin (systemic and topical)

Nil

Resolved

5

Knox [8]

OS

83

M

Explantation of exposed buckle, steroids

NA

20/100

20/60

Topical amikacin 2.5%, TMP-SMX 160/800

Nil

Resolved

6

Choudhry [10]

OS

54

M

Steroids

7 Weeks

20/30

NA

Cefazolin (systemic and topical), TMP-SMX 160/800, 10% sulphacetamide

Surgical debridement

Worsened and lost to follow up

7

Das [9]

OS

40

F

Mud splash, steroids

7 weeks

20/20

20/20

Topical TMP-SMX 160/800, amikacin 2.5%, amoxycillin/clavulanate (800/125 mg)

Nil

Resolved

8

Seth [6]

OD

80

F

Subtenon steroid

3 months

20/400

CF 1 m

Topical trimetho prim/polymixin B, minocycline 100 mg/day

Scleral exploration and biopsy and bovine pericardium patch graft

Resolved

9

Jain [11]

OD-2 OS-1

60.66 ± 7.36

M-3

Scleral buckle—n = 2

1–2 months

20/125–20/400

20/80–20/400

Topical amikacin—all cases, TMP-SMX 160/800—n = 2

Debridement n = 1

Resolved—all

10

DeCroos [12]

OD-8 OS-3

56.8 ± 13

M-11

Injury with organic material—n = 5

30.4 ± 16.8 days

Mean BCVA—20/502

Mean BCVA—20/399

Topical amikacin/ciprofloxacin/cefazolin—n = 11

Surgical debridement—n = 8; conjunctival excision—n = 2; tissue adhesive—n = 1

Resolved

Scleral buckle—n = 1

Systemic amikacin—n = 3

PPV—n = 1

11

Maruo [13]

OS

78

M

Cataract surgery

2 months

20/30

20/16

Topical tobramycin, moxifloxacin, oral TMP-SMX

Debridement

Resolved

  1. OD right eye, OS left eye, NA not available, VA visual acuity, TMP-SMX trimethoprim 160–800, PPV pars plana vitrectomy